Legend Biotech
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $255,954 | $195,053 | $186,522 | $160,205 |
Gross Profit | 151,744 | 123,709 | 112,600 | 104,736 |
EBITDA | -114,121 | -88,870 | 52,459 | -109,910 |
EBIT | -119,996 | -94,069 | 45,663 | -115,382 |
Net Income | -125,820 | -100,916 | 26,284 | -125,321 |
Net Change In Cash | 255,954 | 195,053 | 186,522 | 160,205 |
Free Cash Flow | -22,266 | -105,756 | -84,456 | -77,887 |
Cash | 266,660 | 441,702 | 286,749 | 459,277 |
Basic Shares | 92,067 | 91,881 | 91,425 | 91,363 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $627,241 | $285,143 | $117,005 | $89,792 |
Gross Profit | 392,660 | 140,929 | 51,642 | -223,554 |
EBITDA | -113,159 | -477,873 | -416,536 | -392,379 |
EBIT | -136,518 | -498,324 | -434,928 | -406,296 |
Net Income | -177,026 | -518,254 | -446,349 | -386,209 |
Net Change In Cash | 627,241 | 285,143 | 117,005 | 89,792 |
Free Cash Flow | -158,138 | -415,998 | -222,304 | -245,577 |
Cash | 286,749 | 1,277,713 | 786,031 | 688,938 |
Basic Shares | 91,425 | 88,041 | 79,520 | 70,425 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.03 |
2025-03-31 | -$0.54 |
2024-12-31 | $0.14 |
